CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,906,455 | +310.7% | 798,555 | +201.6% | 0.00% | +200.0% |
Q2 2023 | $2,898,837 | +763.9% | 264,734 | +588.0% | 0.00% | – |
Q1 2023 | $335,546 | +54.8% | 38,480 | +11.3% | 0.00% | – |
Q4 2022 | $216,729 | +79.1% | 34,566 | 0.0% | 0.00% | – |
Q3 2022 | $121,000 | -16.0% | 34,566 | -28.9% | 0.00% | – |
Q2 2022 | $144,000 | -80.6% | 48,612 | -79.7% | 0.00% | – |
Q1 2022 | $744,000 | +22.2% | 239,215 | +32.9% | 0.00% | – |
Q4 2021 | $609,000 | -4.1% | 179,959 | +3.4% | 0.00% | – |
Q3 2021 | $635,000 | -72.6% | 173,959 | -67.3% | 0.00% | -100.0% |
Q2 2021 | $2,317,000 | -5.4% | 531,334 | -1.4% | 0.00% | 0.0% |
Q1 2021 | $2,448,000 | -18.0% | 539,114 | +3.7% | 0.00% | 0.0% |
Q4 2020 | $2,984,000 | -20.8% | 519,693 | -0.1% | 0.00% | -50.0% |
Q3 2020 | $3,768,000 | +147.6% | 520,418 | +19.4% | 0.00% | +100.0% |
Q2 2020 | $1,522,000 | +173.7% | 435,930 | +16.2% | 0.00% | – |
Q1 2020 | $556,000 | -23.3% | 375,265 | +1.5% | 0.00% | – |
Q4 2019 | $725,000 | -63.8% | 369,704 | -5.5% | 0.00% | -100.0% |
Q3 2019 | $2,003,000 | -28.8% | 391,098 | -0.5% | 0.00% | -50.0% |
Q2 2019 | $2,815,000 | -41.9% | 393,123 | +7.7% | 0.00% | -33.3% |
Q1 2019 | $4,847,000 | +90.3% | 364,918 | +12.8% | 0.00% | +50.0% |
Q4 2018 | $2,547,000 | -29.4% | 323,599 | -0.6% | 0.00% | 0.0% |
Q3 2018 | $3,609,000 | +106.6% | 325,651 | +150.2% | 0.00% | +100.0% |
Q2 2018 | $1,747,000 | +559.2% | 130,165 | +539.2% | 0.00% | – |
Q1 2018 | $265,000 | +130.4% | 20,365 | +63.4% | 0.00% | – |
Q4 2017 | $115,000 | – | 12,465 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |